A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction
Public ClinicalTrials.gov record NCT07821372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction (CMD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate whether a fully provided, unrefined, polyphenol-rich plant-based diet can improve blood vessel function in adults with coronary microvascular dysfunction (CMD), a condition that causes reduced blood flow in the small vessels of the heart despite the absence of major coronary artery blockages. Participants will follow the diet for 12 weeks while continuing their usual medical care. Researchers will assess changes in vascular function, symptoms, blood pressure, blood lipids, and other health measures throughout the study. Participants have up to 60 days after consent to complete screening and pre-intervention baseline assessments, potentially over two visits. Day 0 is counseling/education, and diet initiation. Weeks 4, 8, and 12 are measured from Day 0.
Study identification
- NCT ID
- NCT07821372
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
- Last update posted
- Sep 14, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Coronary Microvascular Dysfunction trials
Other public records listing Coronary Microvascular Dysfunction. Sorted by last update posted; newest first. Not a recommendation.
- NCT07093528: A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD Recruiting
- NCT05288361: The DISCOVER INOCA Prospective Multi-center Registry Active, not recruiting
- NCT06843902: Improving Coronary Vascular Health in Women Recruiting
- NCT06795035: Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution Recruiting
- NCT03876223: Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF Recruiting
- NCT05960474: Coronary Microvascular Disease (CMD) Registry Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07821372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2026 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07821372 live on ClinicalTrials.gov.